ExodusPoint Capital Management, LP - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$846,000
+20.2%
26,472
-4.2%
0.01%0.0%
Q3 2021$704,000
+49.2%
27,623
+138.7%
0.01%
+42.9%
Q1 2021$472,000
-86.9%
11,571
-82.4%
0.01%
-90.3%
Q3 2020$3,616,000
-43.8%
65,587
-35.7%
0.07%
-56.9%
Q2 2020$6,439,000
+2395.7%
101,992
+1918.4%
0.17%
+1092.9%
Q1 2020$258,000
+9.8%
5,053
+13.0%
0.01%
+55.6%
Q2 2019$235,0004,4730.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders